Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Human Immunodeficiency Virus
60%
Spike
46%
Vpu
41%
Tetherin
40%
Virus
36%
Interferon Type I
34%
Monospecific Antibody
31%
COVID-19
30%
Neutralizing Antibody
30%
Cells
29%
Epitope
23%
Monoclonal Antibodies
20%
Flow
20%
Heat
20%
Sample
17%
Neutralization
17%
Natural Killer Cell
15%
Virion
14%
Vaccine Efficacy
13%
Mutation
13%
Antibody Response
13%
Virus Release
12%
CD4
12%
Immunity
12%
down Regulation
12%
Viral Replication
12%
Immunoassay
11%
SARS Coronavirus
11%
Light
11%
Upregulation
11%
Receptor Binding
10%
Human Immunodeficiency Virus 1
10%
Cell Membrane
10%
T-Helper Cell
10%
Surface Property
10%
Antigen
10%
Human
10%
Allele
10%
Spleen
10%
Amino Terminal Sequence
8%
Electric Potential
7%
Aptitude
7%
Cytotoxic T Cell
7%
Host
6%
Cell Surface
6%
Comprehension
6%
Development
5%
Medicine and Dentistry
Infection
49%
Severe Acute Respiratory Syndrome Coronavirus 2
30%
COVID-19
23%
Diagnosis
22%
Neutralizing Antibody
22%
Monoclonal Antibody
20%
Immunoassay
20%
Antibody
17%
Serum
15%
Assay
14%
Vaccine
13%
Analysis
13%
Hospital
12%
Epitope
12%
Glycoprotein
12%
SARS Coronavirus
12%
Evaluation Study
11%
Virus
11%
Interferon Type I
10%
Human
10%
Assessment
10%
Human Immunodeficiency Virus
10%
Peyer's Patch
10%
Germinal Center
10%
Syndrome
10%
Atrophy
10%
Receptor Binding
7%
Polymerase Chain Reaction
7%
RNA
6%
Amino Terminal Sequence
6%
Patient
5%
Disease
5%
T Cell
5%
B Cell
5%
Enalapril Maleate
5%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus
60%
Vpu
41%
SARS Coronavirus
40%
Tetherin
40%
Heat
20%
Probe
18%
Phosphorylation
14%
Antibody
13%
Virus
13%
CD4
13%
RNA
12%
Interferon
12%
Allele
11%
Quantitative Reverse Transcription Polymerase Chain Reaction
11%
Upregulation
10%
Neutralizing Antibody
10%
Tyrosine Kinase
10%
Clathrin
10%
Serine
10%
Virion
8%
Sample
8%
Protein
7%
Degradation
6%
Polymerase Chain Reaction
5%
